Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
The goal of this study is to learn if the Mind Over Matter (MOM) Intervention, a 5-week group program, can help Black and African American women deal with the fears, worries and sadness that often accompany cancer diagnosis and treatment. The main question this study aims to answer is: • Whether the MOM Intervention is feasible and acceptable among Black and African American women. We would also like to find out if: * The MOM Intervention decreases anxiety, depression and physical symptom severity for Black and African American women. * The MOM Intervention is culturally and linguistically appropriate, and identify barriers, strengths, and areas of improvement. Participants will: * Attend a Pre-Program Orientation * Attend 5 weekly MOM Sessions * Complete 2 questionnaires (one will be given before the first MOM Session begins, and the other will be given after the last MOM Session) Participants also have the choice to attend an optional Focus Group, which will be offered after the last MOM Session. Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Feb 27, 2025 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Inova Health Care Services
- Interventions being studied
- Other: Mind Over Matter (MOM)
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Self-identify as Black or African American
- Self-identify as female or a woman
- Having received a diagnosis and treatment for any type of cancer
- Having completed primary treatment (completed chemotherapy and/or radiation and/or surgery)
- ≥18 years of age
- Able to understand and provide valid informed consent prior to any study procedure
- Access to the internet and email
- Being able to speak and understand written and spoken English
- Self-identify as other than Black or African American
- Does not Self-identify as a female or a woman
- Does not have a diagnosis of cancer
- Has not completed primary treatment
- Under the age of 18
- Not able to understand and provide valid informed consent
- Does not have access to the internet or email
- Not being able to speak, read and understand English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Howard University Cancer CenterWashington D.C., District of Columbia
- Inova Life With CancerFairfax, Virginia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 27, 2025. Always confirm current availability with the study team.